I'm still here just not as enthusiastic as before because of Ralph's reporting style. I've spent more time discussing stocks where I think management are willing to be more proactive with the market. In my opinion, it's an absolute necessity in the small caps sector.
Like
@athorn says, the proof will have to be in the pudding. Ralph will never change his communication style despite numerous attempts by several of us to communicate that to him via email.
So there isn't much to do but check the FDA EUA page daily.
Hopefully they can secure a second PPP loan to avoid further dilution or interest-bearing finance. The progress on the $4M opportunity for the glucose sensor is a positive and hopefully they'll be further developments on a potential partnership to increase scale and Senera's own line of sensors.
